Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosisMaren Nicole Stillger, Oliver Schilling|Cancer Cell International|2023Cited by 13
Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosisMaren Nicole Stillger, Oliver Schilling|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0